• 文献标题:   Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting
  • 文献类型:   Article
  • 作  者:   JAHANSHAHI M, KOWSARI E, HADDADIASL V, KHOOBI M, LEE JH, KADUMUDI FB, TALEBIAN S, KAMALY N, MEHRALI M
  • 作者关键词:   sericin, chargeswitching propertie, multifunctional fluorinatedgraphene nanomedicine, phresponsivity, curcumin, cancer cells targeting
  • 出版物名称:   INTERNATIONAL JOURNAL OF PHARMACEUTICS
  • ISSN:   0378-5173 EI 1873-3476
  • 通讯作者地址:   Amirkabir Univ Technol
  • 被引频次:   3
  • DOI:   10.1016/j.ijpharm.2019.118791
  • 出版年:   2019

▎ 摘  要

Fluorinated graphene has recently gained much attention for cancer drug delivery, owing to its peculiar properties including high electronegativity difference, magnetic resonance imaging contrast agent, and the photo-thermal effect. However, the hydrophobic nature of fluorinated graphene greatly hinders its application as a biological material. Herein, a novel green method is reported for synthesis of a pH-sensitive charge-reversal and water-soluble fluorinated graphene oxide, modified with polyethyleneimine anchored to sericin-polypeptide (FPS). This nanocarrier was further loaded with curcumin (Cur), and characterized as a nanocarrier for anticancer drug delivery. The synthesized nanocarriers contain two different pH-sensitive amide linkages, which are negatively charged in blood pH (approximate to 7.4) and can prolong circulation times. The amide linkages undergo hydrolysis once they reach the mildly acidic condition (pH approximate to 6.5, corresponding to tumor extracellular matrix), and subsequently once reached the lower acidic condition (pH approximate to 5.5, corresponded to endo/lysosomes microenvironment), the FPS charge can be switched to positive (approximate to + 28 mV), which aids the nuclear release. This nanocarrier was designed to selectively enhance cell internalization and nuclear-targeted delivery of curcumin in HeLa, SkBr3 and PC-3 cancer cells. Moreover, FPS-Cur demonstrated high curcumin loading capacity, prolonged curcumin release and promotion of apoptosis in HeLa, SkBr3 and PC-3 cells. Therefore, with its pH-responsive charge-reversal properties, FPS-Cur would be a promising candidate for chemotherapy of cervical, breast and prostate cancers.